Navigation Links
European Alliance targets separation technologies for sustainable energy systems
Date:5/11/2010

The "European Inorganic Membrane Research Alliance" (EIMRA) aims to facilitate the transition from basic research to applications. In this way, EIMRA will contribute to the worldwide effort to enhance industrial efficiency and reduce carbon dioxide emissions.

Collaboration with industrial partners is of eminent importance for this Alliance. EIMRA seeks to support the industrial implementation of membrane technology by contributing its expertise through the development and realization of membrane pilots and systems. Planned activities are the development of novel membrane materials, manufacturing technologies and processes for membrane modules, and the integration of components into systems. Another goal is that EIMRA should become the single entry point of contact for industry at a European level. EIMRA comprises leading membrane technology groups from the Energy Research Centre of the Netherlands (ECN), the Ris National Laboratory for Sustainable Energy in Denmark (DTU), the Flemish Institute for Technological Research in Belgium (VITO), SINTEF in Norway, and Forschungszentrum Jlich in Germany.

Inorganic (ceramic) membranes can be used in many separation processes in the chemical industry, for example for the production of hydrogen and liquid fuels from renewable sources. Other applications are found in carbon capture technology for fossil-fuel-based power plants. The relatively low energy consumption of membrane technology renders it a key component in a clean, green and sustainable energy system.


'/>"/>

Contact: Kosta Schinarakis
k.schinarakis@fz-juelich.de
0049-246-161-4771
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. 2 French scientists win European award for communication
3. Three-way mating game of North American lizard found in distant European relative
4. European lead in reading past climates from ice cores
5. Hot spots the key to controlling European carp in Australia
6. IdentiPHI Opens Paris Office to Boost European Sales and Support
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. First European Lung Cancer Conference
9. ESFs European ice core project EPICA receives prestigious Descartes Prize
10. European membrane expertise to focus on new treatments for human diseases
11. European light research opens door for optical storage and computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2014)... (April 15, 2014) The American Association of ... winners. All awards will be presented during the ... Marriott Hotel on Tuesday, April 29th at 7:30 p.m. ... , The 2014 award winners are: ... Laitman, PhD, of the Icahn School of Medicine at ...
(Date:4/15/2014)... are many viral diseases in the world for which ... fever, which is spread by mosquitoes in the tropics, ... more familiar in Finland and is easily spread by ... children and the elderly. , Researchers at Aalto University ... in preliminary tests to prevent the spread of one ...
(Date:4/15/2014)... of cuttlefish, squid and octopus has uncovered details ... how they may help in investigating populations of ... described 10 new parasite species− dicyemid mesozoans −, ... squid and octopus). They are the very ... waters. , "Although dicyemid parasites have been ...
Breaking Biology News(10 mins):American Association of Anatomists 2014 award winners 2Nanocrystalline cellulose modified into an efficient viral inhibitor 2Bizarre parasite may provide cuttlefish clues 2
... 2012) Researchers from the University of Minnesota and Washington ... grain products in the United States may have an impact ... published online today in the journal Pediatrics , shows ... to increase, and also finds a notable decrease in two ...
... what makes one particular strain of methicillin-resistant Staphylococcus aureus ... as the one that makes it resistant to vancomycin, ... They report their findings in mBio , the ... on Tuesday May 22. "MRSA strains are leading ...
... Emerita, Stanford University School of Medicine, Stanford, California, has been ... for her years of volunteer service to ASM. "For as ... microbiology, Baron has been the heart and soul of my ... and Development, North America, for bioMrieux, Inc., Durham, NC. ...
Cached Biology News:Folic acid food enrichment potentially protective against childhood cancers 2How one strain of MRSA becomes resistant to last-line antibiotic 2The American Society for Microbiology honors Ellen Jo Baron 2The American Society for Microbiology honors Ellen Jo Baron 3
(Date:1/15/2014)... is the device," Nobel laureate Herbert Kroemer ... to be found at the junctures where ... burgeoning world of nanotechnology, the interfaces between ... prominent, with applications in such high-tech favorites ... Realizing the vast potential of these metal ...
(Date:1/15/2014)... 15, 2014   Niagara Thermal Products ... selected by Buffalo BioBlower Technologies LLC ("B3") as ... its SBIR Phase 2 award from the Army ... comprehensive air purification system that kills all biological ... allergens and organic particulates.  In independent testing sponsored ...
(Date:1/15/2014)... and SAN JOSE, California , ... an international biotechnology company developing antibody-drug conjugates for cancer, ... PhD to its Board of Directors. Dr Reynolds has ... industry, most recently as Chief Medical Officer at Seattle ... at this transformative time for Oxford BioTherapeutics, as the ...
(Date:1/15/2014)... January 15, 2014 A study ... win races on the Formula 1 track could help ... collaboration between McLaren Applied Technologies (MAT), Stowhealth (a GP ... Suffolk is being funded by healthcare provider Simplyhealth. ... to collect data about the on-track performance of Vodafone ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... and Case Volumes Increase 53% and 52% Respectively ... ... Clarient, Inc.,(Nasdaq: CLRT ), a premier technology and services resource ... fourth quarter and year ended December 31, 2007.,Revenue from continuing operations ...
... -- Conference Call on Monday, March 31, ... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider of ... months and twelve months ended December 31,2007., Highlights ... million, up 118% year-over-year -- Record full year ...
... Eisai Co.,Ltd. and its U.S. subsidiary Eisai ... District Court for the District of New,Jersey has ... motion for a,preliminary injunction in its patent infringement ... (collectively,"Teva"), concerning Aricept(R) (generic name: donepezil hydrochloride,tablets)., ...
Cached Biology Technology:Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 2Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 3Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 4Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 5Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 6Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 7Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 8Clarient Announces Fourth Quarter and Year-End 2007 Financial Results 9Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 2Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 3Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 4Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 5Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 6Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 7Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results 8Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals 3
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
IMAGEQUANT 100 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
Request Info...
RayBio Human Cytokine Antibody Array 1.1 (4 array membranes) with Accessory, detects 20 cytokines (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Biology Products: